NVNO (enVVeno Medical) Total Assets: $26.10 Mil (As of Mar. 2026)


NVNO enVVeno Medical Corp NVNO
26 GF Score
Price $11.10
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical Total Assets?

enVVeno Medical NVNO -0.09% 26 Total Assets is $26.10 Mil as of Mar. 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

enVVeno Medical's Total Assets for the quarter that ended in Mar. 2026 was $26.10 Mil.

During the past 12 months, enVVeno Medical's average Total Assets Growth Rate was -28.70% per year. During the past 3 years, the average Total Assets Growth Rate was -19.80% per year. During the past 5 years, the average Total Assets Growth Rate was -3.10% per year. During the past 10 years, the average Total Assets Growth Rate was 2.90% per year.

During the past 11 years, enVVeno Medical's highest 3-Year average Total Assets Growth Rate was 53.70%. The lowest was -19.80%. And the median was -3.45%.

Total Assets is connected with ROA %. enVVeno Medical's annualized ROA % for the quarter that ended in Mar. 2026 was -55.32%. Total Assets is also linked to Revenue through Asset Turnover. enVVeno Medical's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

enVVeno Medical  (NAS:NVNO) Total Assets Explanation

Total Assets is connected with ROA %.

enVVeno Medical's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-15.396/( (29.562+26.097)/ 2 )
=-15.396/27.8295
=-55.32 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

enVVeno Medical's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (29.562+26.097)/ 2 )
=0/27.8295
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

enVVeno Medical Total Assets Related Terms

enVVeno Medical Total Assets Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical Total Assets Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.70 41.66 48.64 44.95 29.56

enVVeno Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.58 36.58 32.35 29.56 26.10
NVNO
26GF Score
enVVeno Medical Corp NVNO
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

enVVeno Medical's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=27.13+2.432
=29.56

enVVeno Medical's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=23.747+2.35
=26.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $26.10 Mil mean?
enVVeno Medical (NVNO) has a Total Assets of $26.10 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on enVVeno Medical and its competitors.
Is enVVeno Medical's Total Assets too high?
enVVeno Medical's current Total Assets is $26.10 Mil. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's Total Assets compare to STME and TRIB?
enVVeno Medical's Total Assets of $26.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on enVVeno Medical and its competitors. enVVeno Medical's current Total Assets is $26.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current Total Assets of $26.10 Mil. The current Total Assets is $26.10 Mil. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current Total Assets is $26.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

enVVeno Medical Business Description

Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for NVNO

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.10
Price